Discover 926 paid clinical trials in Hillsboro, Oregon. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 926
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
for
Non-small Cell Lung Cancer
Location: Salem OR, Olympia WA, Tacoma WA, Seattle WA, Medford OR,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06692738
Phase 3, Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Salem OR, Bellingham WA, Spokane Valley WA, Reno NV,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
BGB-43395 Plus Letrozole Versus CDK4/6i Plus Letrozole for Patients With Advanced or Metastatic HR+/HER2- Breast Cancer Who Have Not Received Prior Treatment for Advanced or Metastatic Disease
for
HR+/HER2- Breast Cancer
Location: Salem OR, Eugene OR, Olympia WA, Tacoma WA, Yakima WA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07492641
Phase 3, Recruiting
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Salem OR, Tacoma WA, San Francisco CA, Los Angeles CA,
Sponsor: Amgen
Sex: Male
Age: 18+
Code: NCT07213674
Phase 3, Recruiting
A Study to Investigate Tislelizumab Administered as Subcutaneous Injection Versus Intravenous Infusion Plus Chemotherapy in Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma
for
Metastatic Gastric Adenocarcinoma,
Location: Salem OR, Tacoma WA, Las Vegas NV, Los Alamitos CA,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07043400
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
CtDNA Based MRD Testing for NAC Monitoring in TNBC
for
TNBC - Triple-Negative Breast Cancer, Minimal Residual Disease
Location: Salem OR, Spokane WA, Aurora CO, Tucson AZ, Omaha NE,
Sponsor: Personalis Inc.
Sex: Female
Age: 18+
Code: NCT06230185
Recruiting
Use of a Novel Device for Stretch Relaxation During Mohs Surgery
Mobility Rehab, a Therapist-assisted System for Gait Rehabilitation
for
Parkinson Disease, Stroke, Multiple Sclerosis,
Location: Salem OR
Sponsor: Oregon Health and Science University
Sex: All
Age: 60 - 70+
Code: NCT03869879
Recruiting
FeaturedActive & Responsive
A Study to Evaluate Safety and Effectiveness of NOA VOLUME Injectable Gel in Adult Participants Compared to JUVÉDERM VOLUMA XC for Improvement of Mid-Face Volume
for
Mid Face Volume Deficit
Location: Portland OR, San Diego CA, Glendale AZ, Austin TX,
Sponsor: AbbVie
Sex: All
Age: 22+
Code: NCT06734351
Phase 3, Recruiting
Featured
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Immunoglobulin Light Chain (AL) Amyloidosis Receiving Etentamig (ABBV-383) as an Intravenous (IV) Infusion
AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain
for
Obesity, Overweight, Osteoarthritis, Knee
Location: Portland OR, Bellevue WA, Lancaster CA, Palm Springs CA,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 18+
Code: NCT07509307
Phase 3, Recruiting
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
for
Chronic Obstructive Pulmonary Disease
Location: Portland OR, West Vancouver, Kelowna, Miami FL,
Sponsor: Sanofi
Sex: All
Age: 40 - 70+
Code: NCT07190222
Phase 3, Recruiting
Efficacy and Safety Study of Ixoberogene Soroparvovec (Ixo-vec) in Participants With Neovascular Age-related Macular Degeneration (AQUARIUS)